Scarica l'app Stockscreener
1.73
3.35%
-0.06
Dopo l'orario di chiusura:
1.79
0.06
+3.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.79
Aprire:
$1.79
Volume 24 ore:
1.01M
Relative Volume:
0.67
Capitalizzazione di mercato:
$263.94M
Reddito:
$137.74M
Utile/perdita netta:
$-27.97M
Rapporto P/E:
-10.81
EPS:
-0.16
Flusso di cassa netto:
$-9.61M
1 W Prestazione:
-8.95%
1M Prestazione:
-16.43%
6M Prestazione:
+1.76%
1 anno Prestazione:
-41.75%
Intervallo 1D:
$1.72
$1.805
Intervallo di 1 settimana:
$1.72
$1.93
Portata 52W:
$1.04
$2.97
Heron Therapeutics Inc Stock (HRTX) Company Profile
Nome
Heron Therapeutics Inc
Settore
Industria
Telefono
(858) 251-4400
Indirizzo
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Confronta HRTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.73 | 273.09M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Iniziato | H.C. Wainwright | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-23 | Iniziato | CapitalOne | Overweight |
| 2024-03-13 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Buy |
| 2020-02-20 | Reiterato | Needham | Buy |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-04-05 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2018-03-01 | Reiterato | Needham | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Outperform |
| 2017-09-27 | Iniziato | Northland Capital | Outperform |
| 2017-02-27 | Iniziato | Needham | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-09-06 | Ripresa | Lake Street | Buy |
| 2016-05-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-10 | Iniziato | Lake Street | Buy |
| 2015-09-23 | Reiterato | Leerink Partners | Outperform |
| 2015-09-02 | Iniziato | BofA/Merrill | Buy |
| 2015-08-03 | Reiterato | Brean Capital | Buy |
| 2015-06-30 | Reiterato | JMP Securities | Mkt Outperform |
| 2015-06-19 | Reiterato | Leerink Partners | Outperform |
| 2014-08-07 | Iniziato | Noble Financial | Buy |
Mostra tutto
Heron Therapeutics Inc Borsa (HRTX) Ultime notizie
How volatile is Heron Therapeutics Inc. stock compared to the marketBreakout Stocks Tips For Beginners - jammulinksnews.com
Does Heron Therapeutics Inc. stock perform well during market downturnsTop Growth Ideas To Watch Now - jammulinksnews.com
When is Heron Therapeutics Inc. stock expected to show significant growthMarket Forecast Planner To Watch Now - jammulinksnews.com
Heron Therapeutics (HRTX) to Release Earnings on Tuesday - MarketBeat
Monaco Asset Management SAM Lowers Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Published on: 2025-07-29 22:59:39 - metal.it
Heron Therapeutics Announces Q2 2025 Earnings Call for August 11, 2025 - AInvest
How does Heron Therapeutics Inc. generate profit in a changing economyMarket Forecast Report For Fast Growth - jammulinksnews.com
Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025 - Yahoo Finance
Biotech Leader Heron Therapeutics Sets Q2 Earnings Call: Key Financial Results Coming August 11 - Stock Titan
What are the technical indicators suggesting about Heron Therapeutics Inc.Unlock powerful trading signals and alerts - jammulinksnews.com
New Product Launches: Will They Boost Heron Therapeutics Inc. Stock in 2025Free Real Time Alerts Based on AI Prediction - Newser
Why is Heron Therapeutics Inc. stock attracting strong analyst attentionMaximize gains with professional stock picks - jammulinksnews.com
How does Heron Therapeutics Inc. compare to its industry peersFree Predictions - jammulinksnews.com
What is Heron Therapeutics Inc. company’s growth strategyFree Stock Market Forecast Reports - jammulinksnews.com
Published on: 2025-07-27 20:33:02 - jammulinksnews.com
What makes Heron Therapeutics Inc. stock price move sharplyShort Term Profit Focus - Newser
AIGH Capital Management LLC Purchases Shares of 2,778,200 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
What institutions are buying Heron Therapeutics Inc. stock nowConsistently superior profits - jammulinksnews.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Holdings Raised by New York State Common Retirement Fund - MarketBeat
Is Heron Therapeutics Inc. stock a growth or value playConsistently superior profits - jammulinksnews.com
Is Heron Therapeutics Inc. a good long term investmentOutstanding investment returns - PrintWeekIndia
How Heron Therapeutics Inc. stock performs during market volatilityFree Wealth-Building Investment Strategies - Newser
Heron Therapeutics Inc. Stock Analysis and ForecastFree Buy/Sell Signal Notifications - Autocar Professional
What analysts say about Heron Therapeutics Inc. stockFree Stock Selection - Autocar Professional
What drives Heron Therapeutics Inc. stock pricePowerful profit generation - jammulinksnews.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by New York State Common Retirement Fund - Defense World
HRTX SEC FilingsHeron Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Is Heron Therapeutics Inc. stock a good hedge against inflationPotential Rocket List - Newser
Heron Therapeutics: Middling Performance From Approved Therapies With No Pipeline - Seeking Alpha
When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Breakeven? - simplywall.st
Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.43%
2.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):